GK
Goetz Kathleen Director
Board F
US US · SEC (Form 4)
€79,019
▲ Purchases (12 ops.)
Discover the complete record of transactions filed by Goetz Kathleen, Director. Officer active across 4 companies, notably Tekla World Healthcare Fund. In total, 12 reports have been recorded. Total volume traded: €79k. The latest transaction was disclosed on 23 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations 12 total
€1,360 69.188 shares @ €19.6605 0.0002% mcap 6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037467:0 · 23 Mar 2022
Ideal exit: 18 Dec 2022 (T+270) €1,362 92.308 shares @ €14.751 0.0003% mcap 6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037465:0 · 23 Mar 2022
Ideal exit: 18 Dec 2022 (T+270) €1,361 73.529 shares @ €18.5098 0.0001% mcap 6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037466:0 · 23 Mar 2022
Ideal exit: 18 Dec 2022 (T+270) €1,361 103.377 shares @ €13.1644 0.0003% mcap 6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037468:0 · 23 Mar 2022
Ideal exit: 18 Dec 2022 (T+270) €9,154 481 shares @ €19.0322 0.0008% mcap 46.5% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008200:0 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,222 714 shares @ €12.9167 100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008203 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,203 593 shares @ €15.5195 100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008199 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,208 479 shares @ €19.2224 100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008201 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,154 481 shares @ €19.0322 100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008200 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,222 714 shares @ €12.9167 0.0018% mcap 46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008203:0 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,203 593 shares @ €15.5195 0.0021% mcap 46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008199:0 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €9,208 479 shares @ €19.2224 0.0013% mcap 46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008201:0 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) About Goetz Kathleen Kathleen Goetz is a Board Member at Tekla World Healthcare Fund, Tekla Life Sciences Investors, and Tekla Healthcare Opportunities Fund. She brings her expertise to the board, contributing to the governance and strategic direction of these investment funds.